Specialty Surgical Oncology secures $2.8 M in funding to accelerate next phase of growth

Specialty Surgical Oncology Hospital (SSO), a chain of surgical cancer hospitals in Western India, has secured $2.8 million in funding from the Everhope Oncology platform, founded and backed by Narayana Health, W Health Ventures and 2070 Health. This investment marks a pivotal moment in SSO’s journey to expand delivery of specialised, affordable cancer care.

SSO was founded in 2021 by a team of 7 cancer surgeons led by Dr Sanket Mehta, a Tata-trained cancer surgeon, to address critical gaps in cancer surgery, particularly the challenges driven by overcrowded hospitals, long waiting times and procedures often performed by general surgeons with limited access to advanced care. SSO is pioneering organ-specific surgical teams that manage even complex cases in facilities dedicated solely to cancer surgeries. Since its inception, SSO has grown to five centres and a team of 20 surgeons, who have collectively performed over 20,000 complex oncology procedures.

As SSO enters its next chapter, it remains anchored in its founding purpose – ensuring that no patient is left behind. With strong clinical leadership, aligned partners and committed capital, SSO is positioned to redefine the delivery of comprehensive cancer treatment at scale, expanding its presence across Western India, including Mumbai, Ahmedabad and major cities in Maharashtra and Gujarat.